Skip to main content
VYNE Therapeutics Inc. logo

VYNE Therapeutics Inc. — Investor Relations & Filings

Ticker · VYNE ISIN · US92941V1008 US Manufacturing
Open in API
Filings indexed 608 across all filing types
Latest filing 2021-02-24 Director's Dealing
Country US United States of America
Listing US VYNE

About VYNE Therapeutics Inc.

https://vynetherapeutics.com/

VYNE Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions. The company's primary objective is to address unmet medical needs by advancing a pipeline of novel drug candidates. VYNE's approach centers on innovating beyond traditional assumptions to find improved solutions for patients with complex inflammatory and immunological diseases.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2021-02-24 English
FORM 4 SUBMISSION
Director's Dealing
2021-02-24 English
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report pursuant to the Securities Exchange Act of 1934. The content describes a reverse stock split event completed by the company, including details about fractional shares and the new number of shares outstanding. There is no detailed financial data or comprehensive report content; rather, it is an announcement of a corporate action. The document is relatively short (4601 characters) and serves as a regulatory disclosure of a capital structure change event. This fits best under Capital/Financing Update (CAP) as it relates to changes in the company's capital structure due to the reverse stock split. It is not an Annual Report, Earnings Release, or other detailed financial report. It is not a Regulatory Filing (RNS) fallback because the content is specific to a capital event. Therefore, the classification is CAP with high confidence.
2021-02-16 English
Major Shareholding Notification 2021
Major Shareholding Notification
2021-02-16 English
SC 13G/A
Major Shareholding Notification
2021-02-16 English
SCHEDULE 13G (AMENDMENT #1)
Major Shareholding Notification
2021-02-16 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.